Stock BNKL BIONIK LABORATORIES CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News Bionik Laboratories Corp.

Equities

BNKL

US09074A2087

Market Closed - OTC Markets
Other stock markets
 08:10:00 2023-11-29 pm EST 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Bionik Laboratories Corp. -.--% -.--%
2023 Bionik Laboratories Corp. Announces Executive Changes CI
2023 Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bionik Laboratories Corp. Announces Executive Changes
CI
Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Bionik Laboratories Corp. Auditor Raises 'Going Concern' Doubt
CI
BIONIK LABORATORIES CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Bionik Laboratories Expands Its Partnership with Lifepoint Health with the Installation of InMotion Robotic Devices at Four New Locations
AQ
Bionik Laboratories : Private Placement - Form 8-K
PU
Bionik Laboratories Corp. Expands Its Partnership With Lifepoint Health With the Installation of InMotion® Robotic Devices at Four New Locations
CI
Bionik Laboratories Corp. announced that it expects to receive $2 million in funding
CI
Bionik Laboratories Reports a Significant Increase in Patient Volume at Its Acquired Rehabilitation Center in Florida
AQ
BIONIK LABORATORIES CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
BIONIK LABORATORIES CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
BIONIK LABORATORIES CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
Bionik Laboratories Corp. announced that it has received $0.25 million in funding
CI
Bionik Laboratories InMotion Robotic Devices on Display at the Korea International Medical and Hospital Equipment Show
AQ
BIONIK LABORATORIES CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
Bionik Laboratories Corp. announced that it has received $0.5 million in funding
CI
Bionik Laboratories Reports Third Quarter Fiscal Year 2023 Financial Results
AQ
BIONIK LABORATORIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Bionik Laboratories Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Earnings Flash (BNKL) BIONIK LABORATORIES Posts Q3 Revenue $575.1M
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BNKL Stock
  4. News Bionik Laboratories Corp.